Point72 Asset Management, L.P. Shows New 8.3% Stake in Celator Pharmaceuticals (CPXX)
Get Alerts CPXX Hot Sheet
Join SI Premium – FREE
In a 13G filing on Celator Pharmaceuticals (NASDAQ: CPXX), Steven Cohen Point72 Asset Management, L.P. disclosed a 8.3%, or 2,855,000 share, stake in the company.
Shares of CPXX surged 432% intra-day on the back of positive trial data.
For more notable holders of Celator Pharmaceuticals stock click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kerrisdale Capital is short Microstrategy, Inc. (MSTR), long bitcoin
- UBS shares swing as analysts flag hit to income, trading briefly halted
- Beyond, Inc. (BYON) Spikes on X Partnership
Create E-mail Alert Related Categories
13Gs, Hedge Funds, Momentum Movers, Trader TalkRelated Entities
SAC Capital, Steven A. Cohen, 13G, Point72 AssetSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!